Summary

Boston Scientific is a medical technology company that designs, develops and markets equipment and instruments in the areas of cardiac surgery, general surgery, wound care management & neurological devices, headquartered in the US with global manufacturing and sales reach. Boston Scientific's product range includes equipment and instruments for cardiac surgery, gastro-enterology, interventional-cardiology, interventional-radiology, neurological surgery products, orthopaedic surgery products, pain medicine products, and urology products. The report, COVID-19 Impact on Boston Scientific Corp's Revenue and Operations (Medical Devices) presents a deep dive analysis into how Boston Scientific Corp is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Deep dive analysis into how Boston Scientific Corp is placed to respond to the COVID-19 crisis, by examining its sector performance and competitiveness.

Key Highlights

- Boston Scientific’s Q1 2020 revenues were much in-line with what was expected by the company due to the extended sales of products in January and February 2020. Even though Q1 2020 results were in-line with the expected results, the company did suffer an organic loss of 2.9% when sales dropped quickly in mid-March as hospitals and clinics canceled most procedures that could be delayed in order to conserve vital medical resources for fighting the pandemic and protecting healthcare workers from COVID-19.
- Despite the impact on medical devices, its MedSurg had a 2.1% organic growth in Q1 2020. However, the Rhythm & Neuro segment suffered an organic loss of 8.6% and the Cardiovascular segment suffered a loss of 2.5%.
- Boston Scientific might see an increase in demand for its resuscitator units (Coventor), personal protective equipment (PPE) kits, and reusable personal respirators in Q2 due to the continuation of the pandemic.

Scope

The report provides a comprehensive analysis of the impact of COVID-19 on Boston Scientific Corp -
- It provides insights on Boston Scientific Corp's exposure to the regions and businesses impacted by the COVID-19 outbreak.
- It offers an overview of the company’s revenue impact by region and market for 2020 due to the COVID-19 outbreak.

Reasons to Buy

- An overview of how Boston Scientific Corp will be affected by the COVID-19 pandemic.